The Women’s Health Initiative (WHI) reported a relative risk (RR) of 1.04 (95% CI 0.72, 1.50) of CRC among postmenopausal women when comparing the highest versus lowest quartile of resistin concentrations (Ho et al. 2012). This evidence concerns the gene RETN and colorectal carcinoma.